WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011019815) TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/019815    International Application No.:    PCT/US2010/045168
Publication Date: 17.02.2011 International Filing Date: 11.08.2010
IPC:
C12N 15/113 (2010.01), A61K 31/7088 (2006.01), A61K 48/00 (2006.01), C12Q 1/68 (2006.01)
Applicants: OPKO CURNA, LLC [US/US]; 4400 Biscayne Boulevard Miami, Florida 33137 (US) (For All Designated States Except US).
COLLARD, Joseph [US/US]; (US) (For US Only).
KHORKOVA SHERMAN, Olga [US/US]; (US) (For US Only)
Inventors: COLLARD, Joseph; (US).
KHORKOVA SHERMAN, Olga; (US)
Agent: BROWDER, Monte R.; OPKO CuRNA, LLC 4400 Biscayne Boulevard Miami, FL 33137 (US)
Priority Data:
61/232,917 11.08.2009 US
61/253,187 20.10.2009 US
Title (EN) TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)
(FR) TRAITEMENT DE MALADIES ASSOCIÉES À L'ADIPONECTINE (ADIPOQ) PAR INHIBITION DU PRODUIT DE TRANSCRIPTION ANTI-SENS NATUREL D'UNE ADIPONECTINE (ADIPOQ)
Abstract: front page image
(EN)The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of an Adiponectin (ADIPOQ), in particular, by targeting natural antisense polynucleotides of an Adiponectin (ADIPOQ). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Adiponectins (ADIPOQ)s.
(FR)La présente invention concerne des oligonucléotides anti-sens, qui modulent l'expression et/ou la fonction d'une adiponectine (ADIPOQ), en particulier en ciblant les polynucléotides anti-sens naturels d'une adiponectine (ADIPOQ). L'invention concerne également l'identification de ces oligonucléotides anti-sens et leur utilisation dans le traitement de maladies et désordres associés à l'expression des adiponectines (ADIPOQ).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)